Emmanouil Fokas

9PUBLICATIONS
20CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|May 13, 2025
Emerging advances and future opportunities in the molecular and therapeutic landscape of anal cancer.

Franz Rödel, Maximilian Fleischmann, Markus Diefenhardt

|Mar 15, 2024
Future direction of total neoadjuvant therapy for locally advanced rectal cancer.

Yoshinori Kagawa, J Joshua Smith, Emmanouil Fokas

|Oct 27, 2023
Early Efficacy End Points in Neoadjuvant Rectal Cancer Trials: Surrogacy Revisited.

Emmanouil Fokas, J Joshua Smith, Julio Garcia-Aguilar

|May 20, 2022
Advances in nanotechnology-based platforms for survivin-targeted drug discovery.

Rosemol George, Stephanie Hehlgans, Maximillian Fleischmann

|Aug 05, 2021
International consensus recommendations on key outcome measures for organ preservation after (chemo)radiotherapy in patients with rectal cancer.

Emmanouil Fokas, Ane Appelt, Robert Glynne-Jones

Pageof 2